iifl-logo

Hikal Ltd Share Price

401.6
(0.10%)
Apr 2, 2025|11:19:48 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open401.2
  • Day's High404
  • 52 Wk High464.75
  • Prev. Close401.2
  • Day's Low394.75
  • 52 Wk Low 266.4
  • Turnover (lac)225.28
  • P/E66.44
  • Face Value2
  • Book Value99.61
  • EPS6.04
  • Mkt. Cap (Cr.)4,951.76
  • Div. Yield0.3
View All Historical Data
No Records Found

Hikal Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

401.2

Prev. Close

401.2

Turnover(Lac.)

225.28

Day's High

404

Day's Low

394.75

52 Week's High

464.75

52 Week's Low

266.4

Book Value

99.61

Face Value

2

Mkt Cap (₹ Cr.)

4,951.76

P/E

66.44

EPS

6.04

Divi. Yield

0.3

Hikal Ltd Corporate Action

22 Aug 2024

12:00 AM

AGM

Announcement Date: 22 Aug, 2024

arrow

22 Aug 2024

12:00 AM

BookCloser

arrow

4 Feb 2025

12:00 AM

Dividend

Dividend Amount: 0.6

Record Date: 08 Feb, 2025

arrow

29 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Hikal Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Hikal Ltd SHAREHOLDING SNAPSHOT

02 Apr, 2025|11:39 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 68.85%

Foreign: 0.00%

Indian: 68.85%

Non-Promoter- 9.53%

Institutions: 9.53%

Non-Institutions: 21.61%

Custodian: 0.00%

Share Price

Hikal Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

24.66

24.66

24.66

24.66

Preference Capital

0

0

0

0

Reserves

1,162.93

1,108.83

1,043.35

908.76

Net Worth

1,187.59

1,133.49

1,068.01

933.42

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

1,720.43

1,507.26

1,296.09

1,013.93

yoy growth (%)

14.14

16.29

27.82

9.53

Raw materials

-908.37

-776.32

-698.97

-509.37

As % of sales

52.79

51.5

53.92

50.23

Employee costs

-164.31

-156.56

-128.05

-116.69

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

206.42

141.98

111.49

83.22

Depreciation

-85.24

-82.46

-85.59

-69.14

Tax paid

-73.28

-42.14

-34.26

-12.54

Working capital

48.62

51.62

54.17

112.99

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

14.14

16.29

27.82

9.53

Op profit growth

18.2

12.99

22.58

8.99

EBIT growth

24.8

21.03

22.14

13.85

Net profit growth

57.68

9.33

9.27

71.04

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,768.7

2,004.7

1,926.03

1,707.06

1,462.12

Excise Duty

0

0

0

0

0

Net Sales

1,768.7

2,004.7

1,926.03

1,707.06

1,462.12

Other Operating Income

15.9

18.33

16.69

13.38

45.14

Other Income

2.5

5.41

4.89

4.98

3.7

Hikal Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,698.35

129.244,07,155.151,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,549.7

71.051,47,295.245940.542,297513.62

Cipla Ltd

CIPLA

1,444.25

25.071,16,664.331,438.150.94,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183.9

59.031,07,673.274850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,458.1

52.421,01,358.17416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Hikal Ltd

Management

Register Office

Registrar Office

Executive Chairman

Jai Hiremath

Managing Director

Sameer Hiremath

Non-Exec & Non-Independent Dir

Sugandha Hiremath

Non-Exec & Non-Independent Dir

Amit B Kalyani

Non-Exec. & Independent Dir.

Shivani Bhasin Sachdeva

Company Sec. & Compli. Officer

Rajasekhar Reddy

Independent Director

Shrikrishna K. Adivarekar

Independent Director

Berjis Minoo Desai

Independent Director

V R Kaundinya

Independent Director

Ravi Brijmohan Kapoor

Independent Director

Ranjana Shivanand Salgaocar

Whole Time Director

Sarangan Suresh

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Hikal Limited, incorporated on July 08th, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals. The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. Presently, it is operating in the crop protection and pharmaceuticals space.The Company has 5 manufacturing facilities across three states in India. It supply products to customers across the globe in the US, Japan, Europe, Canada, South East Asia, LATAM, India and RoW. Apart from this, it specialize in manufacturing APIs and intermediates in pharmaceutical division. Within pharmaceutical division, it offer human health and animal health products.Hikal commenced its first project in 1991 at its first greenfield site at M.I.D.C., Mahad with the manufacture of intermediates for agrochemical industry. It also bagged first big contract with Hoechst. During 1996, Company came with public issue to part finance the expansion project of Thiabendazol. It achieved another milestone when Merck & Co., USA chose Hikal as a partner to outsource Thiabendazole (TBZ, a fungicide). Since the capacity at Mahad was inadequate, Hikal built second greenfield site, a state-of-the-art manufacturing facility at Taloja in 1997. The Company has been accorded Export House status by the Government of India. It set up a new manufactu
Read More

Company FAQs

What is the Hikal Ltd share price today?

The Hikal Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹401.6 today.

What is the Market Cap of Hikal Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Hikal Ltd is ₹4951.76 Cr. as of 02 Apr ‘25

What is the PE and PB ratio of Hikal Ltd?

The PE and PB ratios of Hikal Ltd is 66.44 and 4.11 as of 02 Apr ‘25

What is the 52 Week High and Low of Hikal Ltd?

The 52-week high/low is the highest and lowest price at which a Hikal Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Hikal Ltd is ₹266.4 and ₹464.75 as of 02 Apr ‘25

What is the CAGR of Hikal Ltd?

Hikal Ltd's CAGR for 5 Years at 42.32%, 3 Years at -0.96%, 1 Year at 45.63%, 6 Month at 7.83%, 3 Month at -0.41% and 1 Month at 16.87%.

What is the shareholding pattern of Hikal Ltd?

The shareholding pattern of Hikal Ltd is as follows:
Promoters - 68.85 %
Institutions - 9.54 %
Public - 21.61 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.